1. Volchegorskiy I. A., Tishevskaya N. V., Dementieva E. V. Antianemic eff ect of Reamberin in the acute period of alloxan diabetes in rats // Experimental and Clinical Pharmacology. 2008, 71, 6, 23-27
2. Danilova I. G., Gette I. F., Bulavintseva T. S. Method of modeling alloxan diabetes. Patent RF №2534411. 2014
3. Emelyanov V. V., Savateeva E. A., Sidorova
L. P., Tseitler T. A., Bulavintseva T. S., Gette I. F.,
Danilova I. G., Maksimova N. E., Mochulskaya N. N., Chupakhin O. N., Chereshnev V. A. The correction of metabolic disorders in alloxan diabetes with 1,3,4-thiadiazine derivatives. Russian Immunological Journal, 2015, 9(18), 2(1), 487-489
4. Emelyanov V. V., Leontiev D. V., Ishchenko A. V., Bulavintseva T. S., Savateeva E. A., Danilova I. G. Atomic force microscopy of erythrocytes and metabolic disorders in experimental diabetes mellitus and its correction with lipoic acid // Biophysics. 2016. Т. 61. № 6. S. 922-926
5. Kazakov V. Ya., Postovskiy I. Ya. Syntheses and some reactions of 4-substituted thiosemicarbazides. Reports of the Science Academy of USSR, 1960, 134, 4, 824-827
6. Sidorova L. P., Perova N. M., Egorova L. G., Novikova A. P. Study of reactivity of 1,3,4-thiadiazines in acidic and alkaline media in the transformation into pyrazoles // Abstracts of the I all-Union conference on theoretical organic chemistry. Volgograd, 1991, 232
7. Chupakhin O. N., Sidorova L. P., Perova N. M. et al. 2-aminopropylmorpholine-5-aryl- 6H-1,3,4-thiadiazine, dihydrobromide and 2-aminopropylmorpholine- 4-arylthiazole, hydrobromide possessing antiplatelet eff ect. Patent RF №2456284. 2012.
8. Shestakova S. A., Stepanova R. P., Stepanian M. L., Cherniakova D. N. Structural changes in platelets in alloxan diabetes as parameters of their activation in the vascular bed and morphologic features // Tsitologiia. 1999. Vol. 41, № 2. Р. 122–131.